End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 NZD | +1.03% | -2.98% | -16.29% |
01/05 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
24/04 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.29% | 184M | |
+34.26% | 698B | |
+26.51% | 568B | |
-4.58% | 358B | |
+18.80% | 328B | |
+3.81% | 283B | |
+16.11% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.89% | 165B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- Transcript : AFT Pharmaceuticals Limited, H1 2024 Earnings Call, Nov 23, 2023